Cargando…

Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases

CHAPTER SUMMARY: The nonobese diabetic (NOD) mouse is a well-recognised animal model of spontaneous autoimmune insulin-dependent diabetes mellitus. The disease is T-cell mediated, involving both CD4 and CD8 cells. Its progress is controlled by a variety of regulatory T cells. An unprecedented number...

Descripción completa

Detalles Bibliográficos
Autor principal:	Bach, Jean-François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2002
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3240130/ https://www.ncbi.nlm.nih.gov/pubmed/12110118 http://dx.doi.org/10.1186/ar554

Ejemplares similares

Exploration of Immune Targets for Type 1 Diabetes and Latent Autoimmune Disease Immunotherapy
por: Siddiqui, Khalid, et al.
Publicado: (2023)

Tumor Immunotherapy: Lessons from Autoimmunity
por: Maueröder, Christian, et al.
Publicado: (2014)

Type 1 Diabetes and Autoimmunity
por: Kawasaki, Eiji
Publicado: (2014)

Targeted Immunotherapy for Autoimmune Disease
por: Jung, Seung Min, et al.
Publicado: (2022)

Emerging immunotherapies for autoimmune kidney disease
por: Foster, Mary Helen, et al.
Publicado: (2019)

New Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes
por: Cabello-Olmo, Miriam, et al.
Publicado: (2019)

Repurposing MS immunotherapies for CIDP and other autoimmune neuropathies: unfulfilled promise or efficient strategy?
por: Kohle, Felix, et al.
Publicado: (2023)

Beta cell and immune cell interactions in autoimmune type 1 diabetes: How they meet and talk to each other
por: Scherm, Martin G., et al.
Publicado: (2022)

Immunotherapy in patients with autoimmune disease
por: Rakshit, Sagar, et al.
Publicado: (2020)

SAT-668 Liver Function Test in Type 1 Diabetes Mellitus and Prevalence of Other Autoimmune Disease in Type 1 Diabetes Mellitus
por: Anusha, Nadig, et al.
Publicado: (2020)

Early prediction of autoimmune (type 1) diabetes
por: Regnell, Simon E., et al.
Publicado: (2017)

Autoimmunity to tetraspanin-7 in type 1 diabetes
por: McLaughlin, Kerry A., et al.
Publicado: (2020)

Precipitation of Autoimmune Diabetes With Anti-PD-1 Immunotherapy
por: Hughes, Jing, et al.
Publicado: (2015)

Immunotherapy of Autoimmune Diseases with Nonantibiotic Properties of Tetracyclines
por: Park, Chan-Su, et al.
Publicado: (2020)

Antigen-based immunotherapy for autoimmune disease: current status
por: Hirsch, Darren Lowell, et al.
Publicado: (2014)

Drug Repurposing at the Interface of Melanoma Immunotherapy and Autoimmune Disease
por: Spitschak, Alf, et al.
Publicado: (2022)

The Role of Dendritic Cell Subsets and Innate Immunity in the Pathogenesis of Type 1 Diabetes and Other Autoimmune Diseases
por: Price, Jeffrey D., et al.
Publicado: (2015)

Type 1 diabetes associated with other autoimmune diseases: is there any association with glycemic control and microvascular complications?
por: Campanholo, Ana Luíza, et al.
Publicado: (2015)

Type 1 diabetes and associated autoimmune diseases
por: Frommer, Lara, et al.
Publicado: (2020)

Recent Lessons Learned From Prevention and Recent-Onset Type 1 Diabetes Immunotherapy Trials
por: Staeva, Teodora P., et al.
Publicado: (2013)

Prevalence of other autoimmune diseases in polyglandular autoimmune syndromes type II and III
por: Pham-Dobor, G., et al.
Publicado: (2020)

The Immunopathogenesis and Immunotherapy of Autoimmune Disease
por: Kingsley, Gabrielle, et al.
Publicado: (1993)

On the Mechanisms of the Protective Effect of Infections on Type 1 Diabetes
por: Feillet, Hélène, et al.
Publicado: (2004)

Bioinspired membrane-based nanomodulators for immunotherapy of autoimmune and infectious diseases
por: Shi, Yesi, et al.
Publicado: (2022)

Revisiting the Hygiene Hypothesis in the Context of Autoimmunity
por: Bach, Jean-François
Publicado: (2021)

Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies
por: Gastaldi, Matteo, et al.
Publicado: (2015)

Autoimmune thyroid disease and type 1 diabetes mellitus: same pathogenesis; new perspective?
por: Li, Liyan, et al.
Publicado: (2020)

Lessons from other diseases: granulomatous inflammation in leishmaniasis
por: Kaye, Paul M., et al.
Publicado: (2015)

Primary prevention of beta-cell autoimmunity and type 1 diabetes – The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) perspectives
por: Ziegler, A.G., et al.
Publicado: (2016)

Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis
por: Shin, Taekyun, et al.
Publicado: (2012)

CD4(+) CD25(+) cells in type 1 diabetic patients with other autoimmune manifestations
por: Elaziz, Dalia S. Abd, et al.
Publicado: (2014)

Immunotherapy Deriving from CAR-T Cell Treatment in Autoimmune Diseases
por: Chen, Yuehong, et al.
Publicado: (2019)

Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials
por: Hanefeld, Markolf, et al.
Publicado: (2016)

Autoimmune Endocrine Dysfunctions Associated with Cancer Immunotherapies
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

Therapeutic Use of a Selective S1P(1) Receptor Modulator Ponesimod in Autoimmune Diabetes
por: You, Sylvaine, et al.
Publicado: (2013)

MAIT Cells and Microbiota in Multiple Sclerosis and Other Autoimmune Diseases
por: Mechelli, Rosella, et al.
Publicado: (2021)

The Multifactorial Progression from the Islet Autoimmunity to Type 1 Diabetes in Children
por: Bauer, Witold, et al.
Publicado: (2021)

Impaired hypoglycaemia awareness in type 1 diabetes: lessons from the lab
por: McNeilly, Alison D., et al.
Publicado: (2018)

Coexistence of Autoimmune Encephalitis and Other Systemic Autoimmune Diseases
por: Zhao, Jing, et al.
Publicado: (2019)

Individualizing Targets and Tactics for High-Risk Patients With Type 2 Diabetes: Practical lessons from ACCORD and other cardiovascular trials
por: Riddle, Matthew C., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_b5rn8lq5quesl02qu21j9geir5